Skip to main content

Raquel Hladun Alvaro

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Raquel Hladun Alvaro

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Ensayo clínico Fase I/II para evaluar la seguridad y eficacia de la movilización y colecta de células CD34+ tras tratamiento con plerixafor y filgrastim en pacientes con Anemia de Fanconi para su posterior uso en ensayos de terapia génica

IP: Maria Cristina Díaz de Heredia Rubio
Collaborators: Josep Sánchez de Toledo Codina, Raquel Hladun Alvaro
Funding agency: Ministerio Sanidad
Funding: 437580
Reference: EC11-559
Duration: 01/01/2012 - 30/06/2018

Related news

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

A study jointly led by the Hospital Clínic of Barcelona and the Vall d'Hebron Research Institute (VHIR) confirms the effectiveness of neonatal screening in reducing morbidity among children with sickle cell disease (SCD).

Active participation by patients and families in studies helps identify more effective therapies that improve quality of life and survival.

Related professionals

Jose Fernando Rodríguez Palomares

Jose Fernando Rodríguez Palomares

Main researcher
Cardiovascular Diseases
Read more
Muñoz Vaño, Vicent

Muñoz Vaño, Vicent

Research technician
Nephrology and kidney transplantation
Read more
Català Santarrufina, Alba

Català Santarrufina, Alba

Research technician
Cardiovascular Diseases
Read more
Maria Angeles Jiménez Fuentes

Maria Angeles Jiménez Fuentes

Pneumology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.